Acorda Therapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Acorda Therapeutics Inc.

ACOR 0.880

-13.8%

Apr 10 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: quantman who wrote (106)	2/4/2010 7:32:03 AM
From: kenhott	3 Recommendations Read Replies (1) of 120

You read my posts??? Message 26002877 <I will add one more point. Companies are getting smarter about not putting a red flag on the price of their drug prior to marketing. I believe ACOR was talking about $7 to $12K before and now has been talking $5 to $10k per year. I think they have room to price this drug. But companies have learned, maybe, not to rub it into people's faces. > There is a difference between what one thinks is going to happen and what one cranks into a spreadsheet for public consumption. If you were an analyst, why would you put $12k into your official model when the company is guiding you to $5-$10?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next